281 related articles for article (PubMed ID: 19853535)
21. Convolution method and CTV-to-PTV margins for finite fractions and small systematic errors.
Gordon JJ; Siebers JV
Phys Med Biol; 2007 Apr; 52(7):1967-90. PubMed ID: 17374922
[TBL] [Abstract][Full Text] [Related]
22. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
23. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
Admiraal MA; Schuring D; Hurkmans CW
Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric effect of external beam planning preceding combined high-dose-rate brachytherapy of the prostate.
Martin JM; Brett R; Blyth J; Morrison S; Bryant D; Plank A; Cheuk R; Fay M; Dickie G; Yaxley J
Brachytherapy; 2011; 10(6):474-8. PubMed ID: 21111686
[TBL] [Abstract][Full Text] [Related]
26. Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources.
Zhang H; Baker C; McKinsey R; Meigooni A
Med Dosim; 2005; 30(2):85-91. PubMed ID: 15922174
[TBL] [Abstract][Full Text] [Related]
27. Matched-pair analysis and dosimetric variations of two types of software for interstitial permanent brachytherapy for prostate cancer.
Ishiyama H; Nakamura R; Satoh T; Tanji S; Teh BS; Uemae M; Baba S; Hayakawa K
Med Dosim; 2012; 37(1):84-6. PubMed ID: 21937217
[TBL] [Abstract][Full Text] [Related]
28. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.
Sahgal A; Jabbari S; Chen J; Pickett B; Roach M; Weinberg V; Hsu IC; Pouliot J
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):247-54. PubMed ID: 18722275
[TBL] [Abstract][Full Text] [Related]
29. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
Hille A; Töws N; Schmidberger H; Hess CF
Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
[TBL] [Abstract][Full Text] [Related]
30. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
Morton GC; Sankreacha R; Halina P; Loblaw A
Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
[TBL] [Abstract][Full Text] [Related]
31. Image guidance based on prostate position for prostate cancer proton therapy.
Vargas C; Wagner M; Indelicato D; Fryer A; Horne D; Chellini A; McKenzie C; Lawlor P; Mahajan C; Li Z; Lin L; Keole S
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1322-8. PubMed ID: 18472365
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of dosimetric margins in prostate IMRT treatment plans.
Gordon JJ; Siebers JV
Med Phys; 2008 Feb; 35(2):569-75. PubMed ID: 18383678
[TBL] [Abstract][Full Text] [Related]
33. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
34. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
Todor DA; Barani IJ; Lin PS; Anscher MS
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):297-304. PubMed ID: 21536392
[TBL] [Abstract][Full Text] [Related]
35. Intrafraction prostate translations and rotations during hypofractionated robotic radiation surgery: dosimetric impact of correction strategies and margins.
van de Water S; Valli L; Aluwini S; Lanconelli N; Heijmen B; Hoogeman M
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1154-60. PubMed ID: 24661668
[TBL] [Abstract][Full Text] [Related]
36. Prescription dose in permanent (131)Cs seed prostate implants.
Yue N; Heron DE; Komanduri K; Huq MS
Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric differences between intraoperative and postoperative plans using Cs-131 in transrectal ultrasound-guided brachytherapy for prostatic carcinoma.
Jones A; Treas J; Yavoich B; Dean D; Danella J; Yumen O
Med Dosim; 2014; 39(4):286-91. PubMed ID: 25047330
[TBL] [Abstract][Full Text] [Related]
38. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer.
De Meerleer GO; Villeirs GM; Vakaet L; Delrue LJ; De Neve WJ
Strahlenther Onkol; 2004 Sep; 180(9):573-81. PubMed ID: 15378188
[TBL] [Abstract][Full Text] [Related]
39. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.
White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric comparison between model 9011 and 6711 sources in prostate implants.
Zhang H; Beyer D
Med Dosim; 2013; 38(2):199-203. PubMed ID: 23510715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
